Category: RenalSyndicate content

Renal

Outset Medical raises $60m for home dialysis device

May 20, 2015 by Fink Densford

Home hemodialysis device developer Outset Medical raises $60 million for its Tablo dialysis system.

Outset Medical raises $60m for home dialysis device

Renal denervation: Ablative Solutions wins CE Mark for chemical ablation catheter

May 13, 2015 by Fink Densford

Ablative Solutions wins CE Mark approval in the European Union for its Peregrine infusion ablation catheter for treating uncontrolled hypertension.

Hypertension: Ablative Solutions wins CE Mark for infusion ablation catheter

Ablative Solutions said it received CE Mark approval for its Peregrine infusion ablation catheter for treating uncontrolled hypertension. The company began testing Peregrine last year in Poland.

Renal denervation: Medtronic launches afib trial

April 30, 2015 by Brad Perriello

Medtronic says it's launching a clinical trial evaluating renal denervation and cardiac ablation in treating atrial fibrillation.

Renal denervation: Medtronic launches afib trial

Medtronic (NYSE:MDT) today said it's launching a study of a new, combination treatment for atrial fibrillation using renal denervation and cardiac ablation.

Renal denervation: Boston Scientific launches new Vessix trial

April 17, 2015 by Brad Perriello

Boston Scientific launches a clinical trial of its Vessix renal denervation device in treating hypertension, aiming to separate its effects from drug therapy for high blood pressure.

Renal denervation: Boston Scientific launches new Vessix trial

ReCor Medical raises $15M for ultrasound RDN

April 13, 2015 by Mark Hollmer

ReCor Medical raises a $15 million Series D financing for a planned U.S. study of its ultrasound renal denervation device.

ReCor Medical raises $15M for ultrasound RDN

A Japanese healthcare conglomerate is the lead investor ReCor Medical's $15 million Series D round ReCor plans to use to back a U.S. clinical trial of its ultrasound renal denervation device.

Baxter wins CE Mark for home dialysis device

April 2, 2015 by Brad Perriello

Baxter International wins CE Mark approval in the European Union for its HomeChoice Claria device for home peritoneal dialysis treatments.

Baxter wins CE Mark for home dialysis device

Medtronic takes another crack at renal denervation

April 1, 2015 by Brad Perriello

Medtronic launches a new clinical trial examining renal denervation as a treatment for hypertension, aiming to settle the 'confounding factors' that led to the failure of its Symplicity-3 trial.

Medtronic takes another crack at renal denervation